Ribosome-component immune modulation of respiratory tract infections in adults.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Allergy and Asthma Proceedings

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2500/aap.2009.30.3250PMID 19679001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance

  2015cited by this paper
• Respiratory infections in schoolchildren: co-morbidity and risk factors

  2006cited by this paper
• Gram‐Positive Resistance: Pathogens, Implications, and Treatment Options Insights Society of Infectious Diseases Pharmacists

  2005cited by this paper
• Vancomycin-Tolerance among Clinical Isolates of Streptococcus pneumoniae in Mississippi during 1999-2001

  2005cited by this paper
• The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality.

  2003cited by this paper
• Ribosomal immunostimulation: assessment of studies evaluating its clinical relevance in the prevention of upper and lower respiratory tract infections in children and adults.

  2003cited by this paper
• Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial.

  2002cited by this paper
• Respiratory viral infections in adults

  2002cited by this paper
• Acute upper airway infections

  2002cited by this paper
• Diagnosis and management of acute bronchitis.

  2002cited by this paper
• DIAGNOSIS AND MANAGEMENT OF RESPIRATORY TRACT INFECTIONS FOR THE PRIMARY CARE PHYSICIAN

  2001cited by this paper
• Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

  2001cited by this paper
• Meta-Analysis of Published Clinical Trials of a Ribosomal Vaccine (Ribomunyl®) in Prevention of Respiratory Infections

  2000cited by this paper
• Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease and chronic asthma.

  1997cited by this paper
• Effectiveness of ribosomal fractions ofKlebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction ofKp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis

  1997cited by this paper
• Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant.

  1997cited by this paper
• Pidotimod activity against chronic bronchitis exacerbations.

  1994cited by this paper
• The epidemiology of acute respiratory infections in children and adults: a global perspective.

  1990cited by this paper
• Clinical features and treatment of acute bronchitis.

  1984cited by this paper
• Immunogenic Activity of a Ribosomal Fraction Obtained from Mycobacterium tuberculosis

  1965cited by this paper

• Immunomodulatory effects of the aromatic geranyl derivative filifolinone tested by the induction of cytokine expression.

  2013cites this paper